業績

 

2018年

  • Okiyama N, Asano Y, Hamaguchi Y, Jinnin M, Motegi S, Koizumi H, Hasegawa M, Ishikawa O, Sato S, Takehara K, Yamamoto T, Fujimoto M, Ihn H. Impact of a new simplified disability scoring system for adult patients with localized scleroderma. J Dermatol. 2018 Jan 25.
  • Saito A, Okiyama N, Iwamoto K, Inoue S, Koguchi-Yoshioka H, Fujimoto M. A case with anaphylactic shock induced by heparin lock flish injection. J Dermatol2018 Jan 25.
  • Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K. Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis. Ann Rheum Dis. 2018 Jan 13.
  • Ogawa T, Ishitsuka Y, Iwamoto K, Koguchi-Yoshioka H, Tanaka R, Watanabe R, Fujisawa Y, Fujimoto M. Programmed cell death 1 blockade-induced cutaneous sarcoid-like epithelioid granulomas in advanced melanoma: A case report. J Eur Acad Dermatol Venereol. 2018 Jan 5.
  • Nakamura Y, Fujisawa Y, Okiyama N, Watanabe R, Tanaka R, Ishitsuka Y, Tahara H, Fujimoto M. Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response. J Dermatol Sci. 2017 Dec 29.
  • Hasegawa M, Ishikawa O, Asano Y, Sato S, Jinnin M, Takehara K, Fujimoto M, Yamamoto T, Ihn H; Executive Committee of Guideline. Diagnostic criteria, severity classification and guideline of lichen sclerosus et atrophicus. J Dermatol. 2017 Dec 19.
  • Matsuda T, Ueda-Hayakawa I, Kambe N, Son Y, Ozaki Y, Hamaguchi Y, Takehara K, Fujimoto M, Okamoto H. Four cases of anti-Mi-2 antibody-positive dermatomyositis: relationship between anti-Mi-2 antibody titre and disease severity and activity. J Eur Acad Dermatol Venereol. 2017 Dec 13.
  • Jinnin M, Yamamoto T, Asano Y, Ishikawa O, Sato S, Takehara K, Hasegawa M, Fujimoto M, Ihn H. Guideline for diagnostic criteria, severity classification and treatment of eosinophilic fasciitis. J Dermatol. 2017 Dec 13.
  • Hasegawa M, Ishikawa O, Asano Y, Sato S, Jinnin M, Takehara K, Fujimoto M, Yamamoto T, Ihn H; Executive Committee of Guideline. Diagnostic criteria, severity classification and guideline of lichen sclerosus et atrophicus. J Dermatol. 2017 Dec 19.


2017年

  • Fujisawa Y, Yoshino K, Otsuka A,Funakoshi T, Fujimura T, Yamamoto Y, Hata H, Gosho M, Tanaka R, Yamaguchi K, Nonomura Y, Hirai I, Furudate S, Okuhira H, Imafuku K, Aoki M, Matsushita S. Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab. J Dermatol Sci. 2017 Nov;88(2):225-231.
  • Inoue S, Furuta JI, Fujisawa Y, Onizawa S, Ito S, Sakiyama M, Kobayashi K, Kanou T, Iijima S, Ohi T, Okubo C, Moriyama Y, Okiyama N, Fujimoto MPyoderma gangrenosum and underlying diseases in Japanese patients: A regional long-term study. J Dermatol. 2017 Nov;44(11):1281-1284.
  • Ogawa T, Maruyama H, Tanaka R, Fujisawa Y, Fujimoto M. Clear cell sarcoma of the scalp: A case report. J Dermatol. 2017 Nov;44(11):e276-e277.
  • Oka A, Asano Y, Hasegawa M, Fujimoto M, Ishikawa O, Kuwana M, Kawaguchi Y, Yamamoto T, Takahashi H, Goto D, Endo H, Jinnin M, Mano S, Hosomichi K, Mabuchi T, Ueda MT, Nakagawa S, Beck S, Bahram S, Takehara K, Sato S, Ihn H. RXRB Is an MHC-Encoded Susceptibility Gene Associated with Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis. J Invest Dermatol. 2017 Sep;137(9):1878-1886.
  • Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y. Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis. Ann Rheum Dis. 2017 Jun;76(6):1150-1158.
  • Ogawa T, Okiyama N, Koguchi-Yoshioka H, Fujimoto M. Eosinophilic granulomatosis with polyangiitis followed by venous thromboembolism resulting in severe cutaneous ulcers. J Dermatol. 2017 Sep;44(9):e216-e217.
  • Koguchi-Yoshioka HOkiyama NIwamoto KMatsumura YOgawa TInoue SWatanabe RFujimoto M, Intravenous immunoglobulin contributes to control anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis with palmar violaceous macules/papules. Br J Dermatol. 2017 Nov;177(5):1442-1446.
  • Shibao K, Fujisawa Y, Nakamura Y, Nakamura Y, Maruyama H, Furuta JI, Okiyama N, Ishii Y, Fujimoto M. Cutaneous squamous cell carcinoma treated with preoperative intraarterial chemoradiation therapy. J Dtsch Dermatol Ges. 2017 Jul;15(7):724-726.
  • Togawa R, Tanino Y, Nikaido T, Fukuhara N, Uematsu M, Misa K, Sato Y, Matsuda N, Sugiura Y, Namatame S, Kobayashi H, Hamaguchi Y, Fujimoto M, Kuwana M, Munakata M.Three cases of interstitial pneumonia with anti-signal recognition particle antibody. Allergol Int. 2017 Jul;66(3):485-487.
  • Iwamoto K, Ishitsuka Y, Tanaka R, Sekine I, Fujimoto M. Azathioprine combination therapy for steroid-refractory hepatic immune system-related adverse events. Eur J Dermatol. 2017 Jun 1;27(3):301-303.
  • Saito A, Okiyama N, Saito K, Tanaka R, Maruyama H, Fujimoto M, Case of facial lupus erythematosus profundus with intractable ulceration successfully treated with dapsone. J Dermatol. 2017 May;44(5):e89-e90.
  • Tanaka R, Okiyama N, Okune M, Ishitsuka Y, Watanabe R, Furuta J, Ohtsuka M, Otsuka A, Maruyama H, Fujisawa Y, Fujimoto MSerum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab reactivity. J Dermatol Sci. 2017 Apr;86(1):71-73.
  • Ogawa T, Okiyama N, Koguchi-Yoshioka H, Fujimoto M, Taxane-induced scleroderma-like skin changes resulting in gangrene: A case report. J Dermatol. 2017 Apr;44(4):e54-e55.
  • Maruyama H, Tanaka R, Fujisawa Y, Nakamura Y, Ito S, Fujimoto M. Availability of sentinel lymph node biopsy for cutaneous squamous cell carcinoma. J Dermatol. 2017 Apr;44(4):431-437.
  • Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi YO, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K. Anti-MDA5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol. 2017 Feb;176(2):395-402.
  • Nakamura Y, Tanaka R, Asami Y, Teramoto Y, Imamura T, Sato S, Maruyama H, Fujisawa Y, Matsuya T, Fujimoto M, Yamamoto A. Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi-institutional retrospective study. J Dermatol. 2017 Feb;44(2):117-122.
  • Inoue S, Okiyama N, Okune M, Shiraki N, Kessoku R, Fujimoto M, Clinical and histological characteristics of livedo racemosa in essential thrombocythemia: A report of two cases and review of the published works. J Dermatol. 2017 Jan; 44(1):84-87
  • Hasegawa H, Kawahata K, Mizoguchi F, Okiyama N, Miyasaka N, Kohsaka H, Direct suppression of autoaggressive CD8+ T cells with CD80/86 blockade in CD8+ T cell-mediated polymyositis models of mice. Clin Exp Rheumatol. 2017 Jan 27.

著書・総説

  • 沖山奈緒子「特集:免疫チェックポイント阻害薬:免疫学から理解する副作用 皮膚症状とIL-6」Keynote RA Vol.5 No.3、先端医学社、2017年12月25日
  • 厚生労働科学研究費補助金難治性疾患等政策研究事業 自己免疫疾患に関する調査研究班 診療ガイドライン作成委員会(委員:藤本 学、沖山奈緒子、他)「成人スチル病診療ガイドライン 2017年版」、診断と治療社、2017年11月30日
  • 藤澤康弘「見逃してはいけない皮膚悪性腫瘍」、渡辺 玲「乾癬治療の最前線」Mebio Graphic Medical Magazine Vol.34 No.10、メディカルレビュー社、2017年10月10日
  • 渡辺 玲「ヒト皮膚resident memory T細胞」皮膚アレルギーフロンティア Vol.15 No.2、メディカルレビュー社、2017年7月15日
  • 沖山奈緒子「エリテマトーデスをきわめる─SLEエンサイクロペディア ▼Part2. 非特異的皮疹 case 16 口腔内潰瘍」Visual Dermatology Vol.16 No.8、学研メディカル秀潤社、2017年7月25日
  • 沖山 奈緒子, 田中 亮多特集:がん免疫チェックポイント阻害剤の免疫性副作用 免疫チェックポイント阻害剤によって誘発される多彩な自己免疫反応性副作用 — interleukin-6を介する乾癬様皮膚炎を中心に —」日本臨床免疫学会会誌 40 巻 (2017) 2 号 p. 95-101、2017年6月12日
  • 沖山奈緒子「専門医でも聞きたい 皮膚科診療100の質問 膠原病55 皮膚筋炎は抗体プロフィールで治療方針が変わる?」メディカルレビュー社、2017年6月10日
  • 沖山奈緒子「特集 膠原病はどこまでわかったか? 皮膚筋炎・多発性筋炎の発症メカニズム」皮膚アレルギーフロンティア Vol.15 No.1、メディカルレビュー社、2017年3月15日
  • 沖山奈緒子「特集 厚生労働省指定難病の診断基準と重症度 全身性強皮症」分子リウマチ治療第10巻第1号、先端医学社、2017年1月20日
  • 藤本 学「VII 膠原病および類似疾患 5 限局性強皮症」、沖山奈緒子「VI 紫斑、血管炎 11 好酸球性多発血管炎性肉芽腫症・多発血管炎性肉芽腫症」、渡辺 玲「XVI 感染症 D リケッチア、寄生虫 6 虫刺症」、皮膚疾患最新の治療2017-2018、南江堂、2017年1月30日



2016年

  • Fujimoto M, Murakami A, Kurei S, Okiyama N, Kawakami A, Mishima M, Sato S, Seishima M, Suda T, Mimori T, Takehara K, Kuwana M.Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis. J Dermatol Sci. 2016 Dec;84(3):272-281.
  • Takeuchi A, Matsushita T, Kaji K, Okamoto Y, Yasui M, Hirata M, Oishi N, Higashi A, Seishima M, Asano T, Fujimoto M, Kuwana M, Takehara K, Hamaguchi Y. Autoantibody to scaffold attachment factor B (SAFB): A novel connective tissue disease-related autoantibody associated with interstitial lung disease. J Autoimmun. 2016 Sep; 76:101-107.
  • Ang CC, Anyanwu CO, Robinson E, Okawa J, Feng R, Fujimoto M, Hamaguchi Y, Werth VP. Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositis. Br J Dermatol. 2016 Jun 13
  • Fujimoto M, Watanabe R, Ishitsuka Y, Okiyama N, Recent advances in dermatomyositis-specific autoantibodies. Curr Opin Rheumatology. 2016 Nov;28(6):636-644.
  • Matsushita T, Le Huu D, Kobayashi T, Hamaguchi Y, Hasegawa M, Naka K, Hirao A, Muramatsu M, Takehara K, Fujimoto M. A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase-Akt pathway activation. J Allergy Clin Immunol. 2016 Oct. 138(4):1170-1182.
  • Ohara K, Fujisawa Y, Yoshino K, Kiyohara Y, Kadono T, Murata Y, Uhara H, Hatta N, Uchi H, Matsushita S, Takenouchi T, Hayashi T, Yoshimura K, Fujimoto M. A proposal for a TNM staging system for extramammary Paget disease: Retrospective analysis of 301 patients with invasive primary tumors. J Dermatol Sci. 2016 Sep;83(3):234-239
  • Shibao K, Okiyama N, Tanaka R, Maruyama H, Fujisawa Y, Fujimoto M, Nodulocystic basal cell carcinoma arising directly from a seborrheic keratosis: a rare case report. Indian J Dermatol. 2016 Jul-Aug; 61(4): 443-445.
  • Saito K, Okiyama N, Shibao K, Maruyama H, Fujimoto M. Angioimmunoblastic T-cell lymphoma mimicking dermatomyositis. J Dermatol. 2016 Jul; 43(7):837-839.
  • Tanaka R, Sasajima Y, Tsuda H, Namikawa K, Takahashi A, Tsutsumida A, Fujisawa Y, Fujimoto M, Yamazaki N. Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease. Clin Exp Metastasis. 2016 Jul.
  • Shibao K, Okiyama N, Maruyama H, Furuta J, Fujimoto M. Scleroderma-like skin changes occurring after the use pf paclitaxel without any chemical solvents: a first case report. Eur J Dermatol. 2016 Jun; 26(3):317-318
  • Tanaka R, Fujisawa Y, Maruyama H, Nakamura Y, Yoshino K, Ohtsuka M, Fujimoto M. Nivolumab-induced tyroid dysfunction. Jpn J Clin Oncol. 2016 Jun;46(6):575-9.
  • Mugii N, Hasegawa M, Matsushita T, Hamaguchi Y, Oohata S, Okita H, Yahata T, Someya F, Inoue K, Murono S, Fujimoto M, Takehara K. Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies. PLoS One. 2016 May 11;11(5):e0154746.
  • Saito A, Okiyama N, Maruyama H, Fujimoto M, Immunogloblin A vasculitis associated with HIV infection,  J Dermatol. 2016 Apr; 43(4):444-445
  • Sato S, Murakami A, Kuwajima A, Takehara K, Mimori T, Kawakami A, Mishima M, Suda T, Seishima M, Fujimoto M, Kuwana M. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies. PLoS One. 2016 Apr 26;11(4):e0154285.
  • Furukawa H, Oka S, Kawasaki A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A, Fukui N, Kobayashi K, Osada A, Ihata A, Kondo Y, Nagai T, Setoguchi K, Okamoto A, Okamoto A, Chiba N, Suematsu E, Kono H, Katayama M, Hirohata S, Sumida T, Migita K, Hasegawa M, Fujimoto M, Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N. Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01. PLoS One. 2016 Apr 26;11(4):e0154255.
  • Yang L, Murota H, Shindo S, Yang F, Serada S, Fujimoto M, Naka T, Katayama I. 
    Increased serum CXCR2 ligand levels in livedo vasculopathy with winter ulcerations: Possible contribution of neutrophil recruitment to lesional skin. J Dermatol Sci. 2016 Apr;82(1):57-9.
  • Matsushita T, Hamaguchi Y, Hasegawa M, Takehara K, Fujimoto M. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity. Rheumatology (Oxford). 2016 Feb; 55(2):263-7

著書・総説
  • 沖山奈緒子、第4章 皮膚疾患の基礎知識「27 シェーグレン症候群」、マイスターから学ぶ 皮膚科治療薬の服薬指導術、メディカルレビュー社、2016年11月10日
  • 沖山奈緒子、藤本 学、「皮膚硬化 治療法の選択」、強皮症の基礎と臨床 病態の解明から最新の診療まで、医薬ジャーナル社、2016年8月20日
  • 沖山奈緒子、「ステロイド」皮膚科内服剤の使用法と留意点、Monthly Book Derma. No. 246、全日本病院出版会、2016年7月15日
  • 沖山奈緒子、「新しい膠原病治療薬と今後の展望」皮膚科の薬剤と医療機器~最近10年間の進歩、皮膚科の臨床5月臨時創刊号 58(6)、金原出版、2016年5月31日
  • 藤本 学、「A リウマチ性疾患へのアプローチ 12 リウマチ性疾患の皮膚病変のみかた」リウマチ病学テキスト改訂第2版、診断と治療社、2016年1月5日

2015年

  • Kishi T, Miyamae T, Morimoto R, Ishiguro N, Hamaguchi Y, Fujimoto M, Nagata S, Yamanaka H. Childhood-Onset Anti-Ku Antibody-Positive Generalized Morphea with Polymyositis: A Japanese Case Study. Pediatr Dermatol. 2015 Sep-Oct;32(5):e224-5.
  • Sato S, Nakamura Y, Teramoto Y, Yeh YW, Maruyama H, Nakamura Y, Fujisawa Y, Fujimoto M, Yamamoto A. A novel approach for inguinal lymph node dissection without inguinal skin incision for invasive extramammary Paget disease. Dermatol Ther. 2015 Nov;28(6):351-4. 
  • Nakamura Y, Ohara K, Kishi A, Teramoto Y, Sato S, Fujisawa Y, Fujimoto M, Otsuka F, Hayashi N, Yamazaki N, Yamamoto A. Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma. J Dermatol. 2015 Sep;42(9):861-6.
  • Miyagaki T, Fujimoto M, Sato S. Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research. Int Immunol. 2015 Nov;27(10):495-504.
  • Hamaguchi Y, Matsushita T, Hasegawa M, Ueda-Hayakawa I, Sato S, Takehara K, Fujimoto M. High incidence of pulmonary arterial hypertension in systemic sclerosis patients with anti-centriole autoantibodies. Mod Rheumatol. 2015 Sep;25(5):798-801.
  • Nakamura Y, Ohara K, Kishi A, Teramoto Y, Sato S, Fujisawa Y, Fujimoto M, Otsuka F, Hayashi N, Yamazaki N, Yamamoto A. Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma. J Dermatol. 2015 Sep;42(9):861-6
  • Okiyama N, Hasegawa H, Oida T, Hirata S, Yokozeki Y, Fujimoto M, Miyasaka N and Kohsaka H, Experimental myositis inducible with transfer of dendritic cells presenting a skeletal muscle C protein-derived CD8 epitope peptide, Int Immunol.  2015 Jul;27(7):327-32.
  • Fujisawa Y, Yoshino K, Kiyohara Y, Kadono T, Murata Y, Uhara H, Hatta N, Uchi H, Matsushita S, Takenouchi T, Hayashi T, Fujimoto M, Ohara K. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget's disease: Multi-center, retrospective study of 151 patients. J Dermatol Sci. 2015 Jul;79(1):38-42
  • Okiyama N, Fujimoto M, Clinical perspective and murine models of lichenoid tissue reaction/interface dermatitis. J Dermatol Sci. 2015 Jun;78(3):167-172
  • Tsuji G, Okiyama N, Villarroel VA, Katz SI, Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation. J Allergy Clin Immunol. 2015 May;135(5):1228-1239
  • Hamaguchi Y, Kodera M, Matsushita T, Hasegawa M, Inaba Y, Usuda T, Kuwana M, Takehara K, Fujimoto M. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies. Arthritis Rheumatol. 2015 Apr;67(4):1045-52.
  • Yang L, Fujimoto M, Murota H, Serada S, Fujimoto M, Honda H, Yamada K, Suzuki K, Nishikawa A, Hosono Y, Yoneda Y, Takehara K, Imura Y, Mimori T, Takeuchi T, Katayama I, Naka T. Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon. Rheumatology (Oxford). 2015 Feb;54(2):349-58.
  • Horai Y, Koga T, Fujikawa K, Takatani A, Nishino A, Nakashima Y, Suzuki T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Ida H, Kakugawa T, Sakamoto N, Ishimatsu Y, Mukae H, Hamaguchi Y, Fujimoto M, Kuwana M, Origuchi T, Kohno S, Kawakami A. Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis. Mod Rheumatol. 2015 Jan;25(1):85-9.
  • Kubota N, Fujisawa Y, Nakamura Y, Tanaka R, Saito A, Maruyama H, Ishii Y, Furutra J, Kawachi Y, Fujimoto M. Angiosarcoma of the scalp in a patient with systemic sclerosis. J Dermatol. 2015 Jan;42(1):102-4.

著書・総説
  • 沖山奈緒子、古田淳一、藤本 学、【全身性強皮症とその鑑別疾患-より早期に、正確に診断するために】 (Part2.)皮膚硬化を来す疾患(case 02) 好酸球性(びまん性)筋膜炎、Visual Dermatology15巻1号、2015年12月
  • 沖山奈緒子、藤本 学、「3章 眼瞼腫脹を来す疾患(アレルギー疾患以外) 3 皮膚筋炎」皮膚科・眼科の連携マニュアル 目の周りの病気とその治療、秀潤社、2015年12月31日
  • 厚生労働省科学研究補助金 難治性疾患等政策研究事業 自己免疫疾患に関する調査研究班 多発性筋炎・皮膚筋炎分科会(藤本 学:分科会委員)、「多発性筋炎・皮膚筋炎 治療ガイドライン」、診断と治療社、2015年12月14日
  • 古田 淳一、「症例6 体幹の痒い発疹」「症例10 全身に多発する白斑」「症例23 全身の紅斑,口唇のびらん」「症例24 全身の紅斑,口囲の膿疱」「症例25 全身の紅斑,水疱,びらん」「症例26 全身の鱗屑を伴う紅斑」【皮膚診療ができる!診断と治療の公式44】レジデントノート17巻14号、羊土社、2015年12月10日
  • 沖山奈緒子、「膠原病の皮膚病変のみかた」内科医が診る皮膚疾患 -専門医はこう鑑別・治療している!今日から使えるポイントとコツー、Mebio Graphic Medical Magagine Vol. 32 No.11、メジカルビュー社、2015年11月10日
  • 沖山奈緒子、「エリテマトーデスの診断基準と病型分類」Monthly Book Derma. No. 235、全日本病院出版会、2015年9月15日
  • 沖山奈緒子、藤本 学、「2章 小児皮膚アトラス 57 皮膚筋炎」小児を診る! 皮膚科医の心得、皮膚科の臨床5月増刊号 Vol. 57 No.6、金原出版、2015年5月29日
  • 古田 淳一、「アトピー性皮膚炎のマネージメントの実際」【いまどうなっている?アトピー性皮膚炎】、Mebio Graphic Medical Magagine Vol. 32 No.4、メジカルビュー社、2015年4月10日

2014年

  • Fujisawa Y, Yoshino K, Kadono T, Miyagawa T, Nakamura Y, Fujimoto M. Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study. Br J Dermatol. 2014 Dec;171(6):1493-500.
  • Nakamura Y, Shimizu M, Fujisawa Y, Taguchi S, Nakamura Y, Teramoto Y, Sato S, Yamamoto A. Pedunculated dermatofibrosarcoma protuberans: an unusual presentation. J Dtsch Dermatol Ges. 2014 Dec;12(12):1132-4.
  • Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K, Matsushita T. B cells promote tumor immunity against B16F10 melanoma. Am J Pathol. 2014 Nov;184(11):3120-9.
  • Nakamura Y, Teramoto Y, Tanaka R, Nakamura Y,Maruyama H, Fujisawa Y, Sato S, Fujimoto M,Yamamoto A. Surgical management of umbilical basal cell carcinoma: Published work review and the optimal depth of surgical excision. J Dermatol. 2014 Nov;41(11):992-5.
  • Kabuto M, Fujimoto N, Teramura K, Tateishi M, Hamaguchi Y, Fujimoto M, Tanaka T. A case of dermatomyositis with esophageal fistula in whom blind mucosal biopsy detected occult oropharyngeal carcinoma. Case Rep Dermatol. 2014 Nov 20;6(3):268-73.
  • Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Comparison between taxane-based chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: a single-center experience. J Dermatolog Treat. 2014 Oct;25(5):419-23.
  • Nakamura Y, Fujisawa Y, Teramoto Y, Sato S, Yamada K, Sekine K, Fujimoto M, Otsuka F, Yamamoto A. Tumor-to-bone distance of invasive subungual melanoma: an analysis of 30 cases. J Dermatol. 2014 Oct;41(10):872-7.
  • Okiyama N, Katz SI. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes. J Autoimmun. 2014 Sep;53:1-9.
  • Nakamura Y, Teramoto Y, Sato S, Yamada K, Nakamura Y, Fujisawa Y, Fujimoto M, Otsuka F, Yamamoto A. Axillary giant lipoma: a report of two cases and published work review. J Dermatol. 2014 Sep;41(9):841-4.
  • Yamaoka T, Doi C, Yokomi A, Tanemura A, Murota H, Tani M, Saruban H, Hamaguchi Y, Fujimoto M, Katayama I. Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer. Eur J Dermatol. 2014 Jul-Aug;24(4):490-1.
  • Miyake M, Sakai A, Nishijima C, Kita T, Nitta E, Kawashima A, Hamaguchi Y, Fujimoto M, Inaoki M. Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease. J Dermatol. 2014 Jul;41(7):664-5.
  • Oishi K, Hamaguchi Y, Matsushita T, Hasegawa M, Okiyama N, Dernedde J, Weinhart M, Haag R, Tedder TF, Takehara K, Kohsaka H, Fujimoto M. A crucial role of L-selectin in C protein-induced experimental polymyositis in mice. Arthritis Rheum. 2014 Jul;66(7):1864-71.
  • Fujimoto N, Takayama S, Hamaguchi Y, Fujimoto M, Tanaka T. Pemphigus foliaceus associated with anti-NXP2 autoantibody-positive dermatomyositis. Acta Derm Venereol. 2014 Jul;94(4):478-9.
  • Villarroel VA, Okiyama N, Tsuji G, Linton JT, Katz SI, CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease. J Invest Dermatol. 2014 Jun;134(6):1552-60.
  • Le Huu D, Kimura H, Date M, Hamaguchi Y, Hasegawa M, Hau KT, Fujimoto M, Takehara K, Matsushita T. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease. J Dermatol Sci. 2014 Jun;74(3):214-21.
  • Maruyama H, Ishitsuka Y, Fujisawa Y, Furuta J,  Sekido M, Kawachi Y. B-Myb enhances proliferation and suppresses differentiation of keratinocytes in three-dimensional cell culture. Arch Dermatol Res. 2014 May;306(4):375-84.
  • Fujisawa Y, Maruyama H, Furuta J, Ishii Y, Kawachi Y, Fujimoto M. Case of pigmented epithelioid melanocytoma with lymph node metastases. J Dermatol. 2014 May;41(5):452-3.
  • Fujimoto N, Honda S, Wakabayashi M, Hamaguchi Y, Fujimoto M, Tanaka T. Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease. Mod Rheumatol. 2014 May 20:1-3.
  • Fujisawa Y, Furuta J, Kawachi Y. Dermatofibrosarcoma protuberans mimicking cutaneous sarcoidosis in a patient with lung sarcoidosis. Eur J Dermatol. 2014 Mar-Apr;24(2):276-7.
  • Okiyama N, Furumoto Y, Villarroel VA, Linton JT, Tsai WL, Gutermuth J, Ghoreschi K, Gadina M, O’Shea JJ and Katz SI, Reversal of CD8 T cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor, tofacitinib, J Invest Dermatol. 2014 Apr:134(6):992-1000
  • Kaji K, Fertig N, Medsger TA Jr, Satoh T, Hoshino K, Hamaguchi Y, Hasegawa M, Lucas M, Schnure A, Ogawa F, Sato S, Takehara K, Fujimoto M, Kuwana M. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. Arthritis Care Res (Hoboken). 2014 Apr;66(4):575-84.
  • Hatta Y, Hasegawa M, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K. The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients. Mod Rheumatol. 2014 Mar;24(2):377-9.
  • Fujisawa Y, Fujimoto M. Metastatic cutaneous apocrine carcinoma of the axilla successfully treated using systemic chemotherapy with i.v. epirubicin and cyclophosphamide followed by oral fluorinated pyrimidine. J Dermatol. 2014 Mar;41(3):280-2.
  • Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, Muto H, Tsuyama N, Sato-Otsubo A, Okuno Y, Sakata S, Kamada Y, Nakamoto-Matsubara R, Tran NB, Izutsu K, Sato Y, Ohta Y, Furuta J, Shimizu S, Komeno T, Sato Y, Ito T, Noguchi M, Noguchi E, Sanada M, Chiba K, Tanaka H, Suzukawa K, Nanmoku T, Hasegawa Y, Nureki O, Miyano S, Nakamura N, Takeuchi K, Ogawa S, Chiba S. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014 Feb;46(2):171-5.
  • Araki Y, Ishii Y, Abe Y, Yoshizawa J, Okamoto F, Hozumi Y, Suzuki T. Hermansky-Pudlak syndrome type 4 with a novel mutation. J Dermatol. 2014 Feb;41(2):186-7.
  • Hasegawa M, Asano Y, Endo H, Fujimoto M, Goto D, Ihn H, Inoue K, Ishikawa O, Kawaguchi Y, Kuwana M, Ogawa F, Takahashi H, Tanaka S, Sato S, Takehara K. Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. PLoS One. 2014 Feb 6;9(2):e88150.

2013年

  • Ueda-Hayakawa I, Kusuyama T, Isei T, Ozaki Y, Hamaguchi Y, Fujimoto M, Takehara K, Okamoto H. Cutaneous necrotizing vasculitis in a patient with dermatomyositis positive for anti-PL-7 antibody. Eur J Dermatol. 2013 Nov-Dec;23(6):889-90.
  • Miyagawa F, Okiyama N, Villarroel VA, Katz SI, Identification of CD3+CD4-CD8- T cells as potential regulatory cells in an experimental murine model of graft-versus-host disease (GVHD). J Invest Dermatol. 2013 Nov:133(11):2538-2545
  • Fujisawa Y, Miyazono Y, Kawachi Y, Otsuka F. A case of sterile transient neonatal pustulosis presenting with large flaccid pustules. Pediatr Dermatol. 2013 Nov-Dec;30(6):e238-9.
  • Hasegawa M, Asano Y, Endo H, Fujimoto M, Goto D, Ihn H, Inoue K, Ishikawa O, Kawaguchi Y, Kuwana M, Ogawa F, Takahashi H, Tanaka S, Sato S, Takehara K. Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study. Mod Rheumatol. 2013 Nov;23(6):1076-84.
  • Kasuya A, Hamaguchi Y, Fujimoto M, Tokura Y. TIF1γ-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody. Acta Derm Venereol. 2013 Nov;93(6):715-6.
  • Nakamura Y, Nakamura Y, Saito A, Fujisawa Y, Kawachi Y, Otsuka F. High-grade mucoepidermoid carcinoma of the columella successfully reconstructed using bilateral nasolabial flaps set up in a sandwich shape and an auricular cartilage graft after surgical resection. J Dermatol. 2013 Nov;40(11):911-4.
  • Ishitsuka Y, Kawachi Y, Maruyama H, Taguchi S, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F, .Pituitary tumor transforming gene 1 induces tumor necrosis factor-α production from keratinocytes: implication for involvement in the pathophysiology of psoriasis. J Invest Dermatol. 2013 Nov;133(11):2566-75.
  • Hasegawa M, Hatta Y, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K. Clinical and laboratory features dependent on age at onset in Japanese systemic sclerosis. Mod Rheumatol. 2013 Sep;23(5):913-9.
  • Hamaguchi Y, Fujimoto M, Oishi K, Kitajima S, Wada T, Takehara K. Cutaneous Mycobacterium chelonae infection in a rheumatoid arthritis patient treated with etanercept. Eur J Dermatol. 2013 Sep-Oct;23(5):700-1.
  • Taguchi S, Kawachi Y, Fujisawa Y, Nakamura Y, Furuta J, Otsuka F. Psoriasiform eruption associated with graft-versus-host disease. Cutis. 2013 Sep;92(3):151-3.
  • Kawachi Y, Obara S, Nakamura Y, Fujisawa Y, Nakamura Y, Ishii Y, Ichikawa E, Otsuka F. Ischemic leg ulcer due to vasculopathy associated with neurofibromatosis type 1. Eur J Dermatol. 2013 Jul-Aug;23(4):522-3.
  • Nakamura Y, Kawachi Y, Nakamura Y, Iino Y, Fujisawa Y, Otsuka F. Linear lupus erythematosus profundus involving the muscle with an intractable deep ulcer, successfully treated with surgical excision. Eur J Dermatol. 2013 Jul-Aug;23(4):535-6.
  • Ito K, Imafuku S, Hamaguchi Y, Fujimoto M, Nakayama J. Case report of anti-transcription intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor. J Dermatol. 2013 Jul;40(7):567-9. 
  • Kawachi Y, Ishitsuka Y, Maruyama H, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Ichikawa E, Otsuka F. The POU domain transcription factors Oct-6 and Oct-11negatively regulate loricrin gene expression in keratinocytes: association with AP-1 and Sp1/Sp3. Arch Dermatol Res. 2013 Jul;305(5):371-8.
  • Huu DL, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Fujimoto M. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin. Arthritis Rheum. 2013 Jun;65(6):1624-35.
  • Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, Naka K, Hirao A, Takehara K, Fujimoto M. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol. 2013 Jun;131(6):1674-82.
  • Nakamura Y, Fujisawa Y, Nakamura Y, Maruyama H, Furuta J, Kawachi Y, Otsuka F. Improvement of the sentinel lymph node detection rate of cervical sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in head and neck skin cancer. J Dermatol. 2013 Jun;40(6):453-7.
  • Maruyama H, Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Penile preservation surgery in a case of erythroplasia of Queyrat involving the glans penis and distal urethra. Int J Dermatol. 2013 May 15.
  • Nakamura Y, Iino Y, Nakamura Y, Fujisawa Y, Kawachi Y, Otsuka F. Intraneural granular cell tumor of the dorsal ramus of a thoracic nerve. Indian J Dermatol Venereol Leprol. 2013 Mar-Apr;79(2):258-60.
  • Le Huu D, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Tedder TF, Fujimoto M. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood. 2013 Apr 18;121(16):3274-83.
  • Hara S, Henmi T, Kawakami A, Fujikawa K, Mukae H, Ishimatsu Y, Sakamoto N, Kakugawa T, Kaji K, Fujimoto M, Kuwana M, Tsukada T, Satoh K, Motomura M, Tamai M, Nakamura H, Ida H, Hayashi T, Origuchi T, Eguchi K, Kohno S. Clinical, serologic and magnetic resonance imaging of 3 cases of inflammatory myopathy with abundant macrophages in the Japanese population. Rheumatol Int. 2013 Apr;33(4):1059-64.
  • Hasegawa M, Higashi K, Matsushita T, Hamaguchi Y, Saito K, Fujimoto M, Takehara K. Dermokine inhibits ELR(+)CXC chemokine expression and delays early skin wound healing. J Dermatol Sci. 2013 Apr;70(1):34-41.
  • Kawachi Y, Maruyama H, Ishitsuka Y, Fujisawa Y, Furuta J, Nakamura Y, Ichikawa E, Furumura M, Otsuka F. NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells. Exp Dermatol. 2013 Apr;22(4):262-5.
  • Kawashima H, Kawachi Y, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Ichikawa E, Otsuka F. Circumscribed palmar hypokeratosis: implication of suppression of early epidermal differentiation. Eur J Dermatol. 2013 Apr 1;23(2):261-2.
  • Arai M, Ikawa Y, Chujo S, Hamaguchi Y, Ishida W, Shirasaki F, Hasegawa M, Mukaida N, Fujimoto M, Takehara K. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis. J Dermatol Sci. 2013 Mar;69(3):250-8.
  • Hasegawa M, Fujimoto M, Matsushita T, Hamaguchi Y, Takehara K. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2013 Feb;52(2):242-51.
  • Hasegawa M, Imura-Kumada S, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K. Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis. J Dermatol. 2013 Feb;40(2):89-93.
  • Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Docetaxel was effective in the management of metastatic angiosarcoma associated with disseminated intravascular coagulation syndrome. Int J Dermatol. 2014 Feb;53(2):e138-40.
  • Honda N, Jinnin M, Kira-Etoh T, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3. Am J Pathol. 2013 Jan;182(1):206-16.
  • Fujimoto M, Matsushita T, Hamaguchi Y, Kaji K, Asano Y, Ogawa F, Yamaoka T, Fujikawa K, Tsukada T, Sato K, Echigo T, Hasegawa M, Takehara K. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis. 2013 Jan;72(1):151-3.
  • Horai Y, Isomoto E, Koga T, Okada A, Kawashiri SY, Tamai M, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Kuwana M, Kawakami A. Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases. Mod Rheumatol. 2013 Jan;23(1):190-4.
  • Ueda-Hayakawa I, Hasegawa M, Hamaguchi Y, Takehara K, Fujimoto M. Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts. J Dermatol Sci. 2013 Jan;69(1):54-60. 
  •  Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One. 2013;8(4):e60442.

2012年

  • Fujisawa Y, Otsuka F : The benefit of sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multi-center, retrospective study of 291 Japanese patients Melanoma Res 22(5): 362-367, 2012
  • Okiyama N, Sugihara T, Oida T, Ohata J, Yokozeki H, Miyasaka N, Kohsaka H. T lymphocytes and muscle condition act like seeds and soil in a murine polymyositis model. Arthritis Rheum. 2012 Nov:64(11):3741-9
  • Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F : Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer J Surg Oncol 106(1):41-45, 2012
  • Nakamura Y, Nakamura Y, Ishitsuka Y, Maruyama H, Fujisawa Y, Kawachi Y, Otsuka F : Facial nerve morbidity following facial nerve preservation surgery for the treatment of skin cancer of the head and neck J Eur Acad Dermatol Venereol 26 (10): 1323-1325, 2012
  • Ishitsuka Y, Kawachi Y, Taguchi S, Maruyama H, Fujisawa Y, Furuta J, Nakamura Y, Otsuka F : Pituitary tumor-transforming gene 1 enhances proliferation and suppresses early differentiation of keratinocytes J Invest Dermatol 132 (7): 1775-1784, 2012
  • Nakamura Y, Fujisawa Y, Ishikawa M, Nakamura Y, Ishitsuka Y, Maruyama H, Furuta J, Kawachi Y, Otsuka F : Usefulness of sentinel lymph node biopsy for extramammary Paget disease Br J Dermatol 167 (4):954-956, 2012
  • Kawachi Y, Furuta J, Fujisawa Y, Nakamura Y, Ishii Y, Otsuka F : Indolent subcutaneous panniculitis-like T cell lymphoma in a 1-year-old child Pediatr Dermatol 29 (3): 374-347, 2012
  • Nakamura Y, Shibata-Ito M, Nakamura Y, Ishitsuka Y, Fujisawa Y, Kawachi Y, Otsuka F : Malignant blue nevus arising in a giant congenital cellular blue nevus in an infant Pediatr Dermatol 29(5):651-655, 2012
  • Ishitsuka Y, Furuta J, Miyashita T, Otsuka F : Splicing aberration in naevoid basal cell carcinoma syndrome Acta Derm Venereol 92 (6): 619-620, 2012
  • Nakamura Y, Satomi K, Noguchi M, Shibata-Ito M, Fujisawa Y, Kawachi Y, Otsuka F : Incidental Gastric Signet-ring Cell Carcinoma Metastasis to the Skin in Basal Cell Carcinoma Acta Derm Venereol 92(6):635-636, 2012
  • Kawachi Y, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F : Pruritic poikilodermatous eruption associated with dermatomyositis: successful treatment with dapsone Eur J Dermatol 22 (2): 289-290, 2012
  • Nakamura Y, Nakamura Y, Fujisawa Y, Obara S, Furuta J, Kawachi Y, Otsuka F : Multiple inguinal and pelvic lymph node metastases of malignant melanoma of the heel identified by common iliac lymphadenopathy Lymphat Res Biol 10 (3):118-121, 2012
  • 前田麻衣子,古田淳一,多島新吾,大塚藤男 : 抗てんかん薬臭化カリウム内服により生じたBromoderma 皮膚臨床 54 (2): 233-236,165-166, 2012
  • 田中亮多,石井良征,中村貴之,中村泰大,川内康弘,大塚藤男 : 両下顎に硬結性局面を生じた白癬菌性毛瘡の1例 皮膚臨床 54 (2): 245-248, 2012
  • 藤澤康弘,大塚藤男,山本明史,山﨑直也,斎田俊明,石原和之 : 本邦における悪性黒色腫の統計:2006,2007年度全国定点調査と2005~2010年度全国追跡調査の集計 Skin Cancer. 27 (2): 195-204, 2012
  • 前田麻衣子,古田淳一, 多島新吾,大塚藤男 : Papular Purpuric Gloves and Socks Syndrome 皮膚臨床 54 (8): 1070-1074, 2012
  • 久保田典子,古田淳一,大塚藤男,狩野俊幸 : 肺結核に併発したSweet病 皮膚病診療 34 (8): 767-770, 2012
  • 藤澤康弘,大塚藤男 : 術後補助療法(DAVFeron、フェロン療法、フェロン維持療法)は悪性黒色腫ステージⅡ・Ⅲ患者の予後を改善するか:831例の解析 日皮会誌 122 (9): 2305-2311, 2012
  • 宮崎郁,古田淳一,小林桂子,川内康弘,大塚藤男 : 好酸球増多症を伴ったBuerger病 皮膚病診療 34 (11): 1107-1110, 2012
  • 藤澤康弘,中村泰大,丸山浩,中村貴之,川内康弘,大塚藤男 : インドシアニングリーンを用いた蛍光法によるセンチネルリンパ節生検50例のまとめ 日皮会誌 122 (12): 2875-2884, 2012
  • 石塚洋典,川内康弘,藤澤康弘,田口詩路痲,大塚藤男 : pituitary tumor transforming gene 1の表皮細胞の分化における役割 第26回角化症研究会記録集 12-16, 2012

ページ上部へ戻る

2011

  • Taguchi S, Kawachi Y, Ishitsuka Y, Fujisawa Y, Furuta J, Nakamura Y, Xu X, Ikebe D, Kato M, Otsuka F: Overexpression of the transcription factor Yin-Yang-1 suppresses differentiation of HaCaT cells in three-dimensional cell culture J Invest Dermatol,131 (1): 37-45, 2011
  • Okiyama N, Kitajima T, Ito Y, Yokozeki H, Miyasaka N, Kohsaka H. Assition of the collagen binding domain of ficronectin potentiates the biochemical availability of hepatocyte growth factor for cutaneous wound healing. J Dermatol Sci 61(3): 215-217, 2011
  • Fujisawa Y, Nabekura T, Nakamura Y, Furuta J, Ishii Y, Kawachi Y, Otsuka F, Onodera M : The enforced expression of RORgammat in hematopoietic stem cells increased Treg cells resulting in in vivo immune balance skewed to declined immunoreactivity Asian Pac J Allergy Immunol. 29 (1): 86-93, 2011
  • Fujisawa Y, Ito M, Mori K, Okada S, Nakamura Y, Kawachi Y, Otsuka F : Intra-arterial mitoxantrone/paclitaxel in angiosarcoma of the lower limb associated with chronic lymphedema (Stewart-Treves syndrome) in a patient with cervical cancer: a case report Eur J Dermatol 21 (1): 119-120, 2011
  • Kawachi Y, Tanaka R, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F : Superficial malignant peripheral nerve sheath tumor arising from a solitary cutaneous neurofibroma in a non-NF1 patient Eur J Dermatol 21 (1): 125-126, 2011
  • Kawachi Y, Taguchi S, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F : Linear childhood discoid lupus erythematosus following the lines of blaschko: successfully treated with topical tacrolimus Pediatr Dermatol, 28 (2): 205-207, 2011
  • Kawachi Y, Hirota A, Otsuka F : Acceleration of UVB-induced photoaging in nrf2 gene- deficient mice Photomed Photobiol 33: 23-24, 2011
  • Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F : A handmade, low-cost intraoperative fluorescence navigation system with indocyanicne green for sentinel lymph node biopsy in skin cancer Dermatology. 222 (3): 261-268, 2011
  • Ishitsuka Y, Ohara K, Otsuka F : Atypical fibrous histiocytoma of the skin with necrobiotic granuloma-like features. Acta Derm Venereol 91(4): 482-483, 2011
  • Nakayama M, Tabuchi K, Nakamura Y, Hara A : Basal cell carcinoma of the head and neck J Skin Cancer. 2011;2011:496910.
  • Nakamura Y, Fujisawa Y, Maruyama H, Furuta J, Kawachi Y, Otsuka F : Intraoperative mapping with isosulfan blue of lymphatic leakage during inguinal lymph node dissection (ILND) for skin cancer for the prevention of postoperative lymphocele J Surg Oncol 104 (6): 657-660, 2011
  • Kawachi Y, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F : Superficial epithelioma with sebaceous differentiation: immunohistochemical study of keratinocyte differentiation markers. Eur J of Dermatol 21 (6): 1016-1017, 2011
  • Fujisawa Y, Sugita S, Kawachi Y, Otsuka F : A case of extra-abdominal desmoid tumor in the subcutis of the thigh J Dermatol 38 (8): 810-812, 2011
  • 丸山浩,中村泰大,藤澤康弘,川内康弘,大塚藤男 : Malignant peripheral nerve sheath tumorの3例 日レ病学誌 2 (1): 81-84, 2011
  • 宮崎郁,丸山浩,古田淳一,川内康弘,大塚藤男 : Schweninger-Buzzi型特発性斑状皮膚萎縮症 皮膚病診療 33 (1): 71-74, 2011
  • 古田淳一,石井良征,大塚藤男 : イミキモド外用で治療した尖圭コンジローマ 皮膚病診療 33 (1): 39-42, 2011
  • 鬼澤沙織,石川雅士,永江美香子,古田淳一 : 化学療法の爪障害に対するアクリル人工爪治療 皮膚病診療 33 (3): 295-298, 2011
  • 前田麻衣子,古田淳一,大塚藤男,千貫祐子,森田栄伸 : アスピリンと運動により増強し,前投与薬により抑制できた小麦による蕁麻疹 皮膚病診療 33 (5): 531-532, 2011
  • 前田麻衣子,古田淳一,大塚藤男 : 胸部と腹部に生じたMondor病 皮膚病診療 33 (9): 901-904, 2011
  • 前田麻衣子,古田淳一,伴野朋裕,多島新吾,大塚藤男,山田信博 : 皮膚黄色腫症を契機に診断した原発性高コレステロール血症の幼児例 皮膚臨床 53 (13): 1931-1935, 1853-1854, 2011
  • 下條信威,越田隆介,斉藤明允,中村泰大,萩谷圭一,西野衆文,安田貢,河野了,水谷太郎 : 重症熱傷に合併したDIC症例に対してトロンボモデュリンアルファを使用した一例 Thrombosis Medicine 1(2): 219-223, 2011
  • 中村泰大,藤澤康弘,丸山浩,中村貴之,古田淳一,川内康弘,大塚藤男 : 鼠径リンパ節郭清後リンパ漏予防のための術中パテントブルー注射による損傷リンパ管同定 日本皮膚外科学会雑誌16 (1): 78-79, 2011
  • 中村貴之,中村泰大,藤澤康弘,石塚洋典,丸山浩,鬼澤沙織,川内康弘,大塚藤男 : 女性外陰部悪性腫瘍切除後欠損に対するV-Y advancement type gluteal fold flapの問題点に関する検討 日本皮膚外科学会雑誌16 (1): 68-70, 2011
  • 鈴木麻衣子,古田淳一,大塚藤男 : ステロイド外用によるクッシング症候群を来した乾癬の2例 第25回日本乾癬学会記録集 230, 2011

総 説

  • 藤澤康弘 : 皮膚科セミナリウム 悪性間葉系腫瘍 脈管系悪性腫瘍 日皮会誌. 121 (4): 3323-3329, 2011
  • 中村泰大, 川内康弘 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part1)頭頸部~躯幹 (QUESTION03)頭部の小結節 Visual Dermatol 10 (6): 561-562, 2011
  • 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part1)頭頸部~躯幹 (QUESTION10)顔面の多発性丘疹・小結節 Visual Dermatol 10 (6): 567-568, 2011
  • 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part1)頭頸部~躯幹 (QUESTION16)外陰部周囲に多発する結節 Visual Dermatol 10 (6): 573-574, 2011
  • 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION35)体幹の多発性丘疹 Visual Dermatol 10 (6): 595-596, 2011
  • 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION36)背部に多発する赤褐色斑 Visual Dermatol 10 (6): 595-596, 2011
  • 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION38)背部の色素沈着 Visual Dermatol 10 (6): 597-598, 2011
  • 中村泰大, 大原國章 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION39)臀部~大腿の茶褐色斑. Visual Dermatol 10 (6): 599-600, 2011
  • 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION40)腰部の軟らかい結節 Visual Dermatol 10 (6): 599-600, 2011
  • 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION41)手背~前腕の皮斑 Visual Dermatol 10 (6): 601-602, 2011
  • 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION44)手背の褐色斑、脱色素斑 Visual Dermatol 10 (6): 603-604, 2011
  • 梅林芳弘, 丸山浩, 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION50)踵内側の多発性丘疹 Visual Dermatol 10 (6): 609-610, 2011
  • 井上雄二, 長谷川稔, 前川武雄, レパヴー・アンドレ, 浅野善英, 安部正敏, 石井貴之, 伊藤孝明, 爲政大幾, 今福信一, 入澤亮吉, 大塚正樹, 大塚幹夫, 小川文秀, 門野岳史, 小寺雅也, 川上民裕, 川口雅一, 久木野竜一, 幸野健, 境恵祐, 高原正和, 谷岡未樹, 中西健史, 中村泰大, 橋本彰, 林昌浩, 藤本学, 藤原浩, 松尾光馬, 間所直樹, 山崎修, 吉野雄一郎, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  創傷一般. 日皮会誌121 (8): 1539-1559, 2011
  • 立花隆夫, 今福信一, 入澤亮吉, 大塚正樹, 門野岳史, 藤原浩, 浅野善英, 安部正敏, 石井貴之, 爲政大幾, 伊藤孝明, 井上雄二, 大塚幹夫, 小川文秀, 小寺雅也, 川上民裕, 川口雅一, 久木野竜一, 幸野健, 境恵祐, 高原正和, 谷岡未樹, 中西健史, 中村泰大, 橋本彰, 長谷川稔, 林昌浩, 藤本学, 前川武雄, 松尾光馬, 間所直樹, 山崎修, 吉野雄一郎, レパヴー・アンドレ, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  褥瘡診療ガイドライン 日皮会誌 121 (9): 1791-1839, 2011
  • 爲政大幾, 安部正敏, 中西健史, 松尾光馬, 山崎修, 浅野善英, 石井貴之, 伊藤孝明, 井上雄二, 今福信一, 入澤亮吉, 大塚正樹, 大塚幹夫, 小川文秀, 門野岳史, 小寺雅也, 川上民裕, 川口雅一, 久木野竜一, 幸野健, 境恵祐, 高原正和, 谷岡未樹, 中村泰大, 橋本彰, 長谷川稔, 林昌浩, 藤本学, 藤原浩, 前川武雄, 間所直樹, 吉野雄一郎, レパヴー・アンドレ, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  糖尿病性潰瘍・壊疽ガイドライン 日皮会誌 121 (10): 1997-2035, 2011
  • 藤本学, 浅野善英, 石井貴之, 小川文秀, 川上民裕, 小寺雅也, 安部正敏, 爲政大幾, 伊藤孝明, 井上雄二, 今福信一, 入澤亮吉, 大塚正樹, 大塚幹夫, 門野岳史, 川口雅一, 久木野竜一, 幸野健, 境恵祐, 高原正和, 谷岡未樹, 中西健史, 中村泰大, 橋本彰, 長谷川稔, 林昌浩, 藤原浩, 前川武雄, 松尾光馬, 間所直樹, 山崎修, 吉野雄一郎, レパヴー・アンドレ, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  膠原病・血管炎にともなう皮膚潰瘍診療ガイドライン 日皮会誌 121 (11): 2187-2223, 2011
  • 伊藤孝明, 久木野竜一, 高原正和, 谷岡未樹, 中村泰大, 浅野善英, 安部正敏, 石井貴之, 爲政大幾, 井上雄二, 今福信一, 入澤亮吉, 大塚正樹, 大塚幹夫, 小川文秀, 門野岳史, 川上民裕, 川口雅一, 幸野健, 小寺雅也, 境恵祐, 中西健史, 橋本彰, 長谷川稔, 林昌浩, 藤本学, 藤原浩, 前川武雄, 松尾光馬, 間所直樹, 山崎修, 吉野雄一郎, レパヴー・アンドレ, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  下腿潰瘍・下肢静脈瘤診療ガイドライン 日皮会誌 121 (12): 2431-2448, 2011
  • 吉野雄一郎, 大塚幹夫, 川口雅一, 境恵祐, 橋本彰, 林昌浩, 間所直樹, 浅野善英, 安部正敏, 石井貴之, 爲政大幾, 伊藤孝明, 井上雄二, 今福信一, 入澤亮吉, 大塚正樹, 小川文秀, 門野岳史, 川上民裕, 久木野竜一, 幸野健, 小寺雅也, 高原正和, 谷岡未樹, 中西健史, 中村泰大, 長谷川稔, 藤本学, 藤原浩, 前川武雄, 松尾光馬, 山崎修, レパヴー・アンドレ, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  熱傷診療ガイドライン 日皮会誌 121 (14): 3279-3306, 2011

著 書

  • Ogawa H, Ishibashi Y, Kitajima Y, Otsuka F, Hashimoto T, Manabe M eds.: The Color Atlas of Disorders of Keratinization Kyowa Kikaku, Ltd., Tokyo, 2011